Please turn JavaScript on

JUVE Patent

Subscribe to JUVE Patent’s news feed.

Click on “Follow” and decide if you want to get news from JUVE Patent via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to JUVE Patent comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from JUVE Patent which you are really interested in. Click on the blue “Filter” button below to get started.

Title: JUVE Patent

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.02 / day

Message History

According to the UPC register, the proceedings concerning EP 4 250 732, over which Nokia had sued Warner Bros. and Paramount in autumn 2025, were withdrawn before Easter (case IDs:


Read full story

Finnish company Suinno is the owner of EP 2 671 173 covering a “method and means for browsing by walking”. It relates to people browsing the internet by walking to discover search results as they come into close proximity.

The Helsinki-based company accuses ...


Read full story

Silimed has achieved its first success in the infringement dispute over breast implant technology. After the Brazilian manufacturer secured the rights to a patent for the manufacture of breast implants in a complex entitlement action, Silimed is now taking measures against its German competitor and the former owner of the patent, Polytech.

At the centre of the dispute ...


Read full story

Once again, the Hamburg local division under presiding judge Sabine Klepsch has prohibited Chinese manufacturer Dreame from distributing certain hair styling devices in the UPC territory and Spain by means of a preliminary injunction. A


Read full story

Nalmefene is an opioid antagonist used in the EU to reduce alcohol dependence. The active ingredient works by antagonising those receptors in the brain responsible for producing the body’s feel-good chemical, dopamine. This prevents the alcohol-induced release of this chemical, resulting in reduced desire to continue drinking.

The drug is sold by Lundbeck under the bra...


Read full story